Your browser doesn't support javascript.
loading
Review article epithelial to mesenchymal transition­associated microRNAs in breast cancer.
Javdani, Hossein; Mollaei, Homa; Karimi, Farzaneh; Mahmoudi, Shiva; Farahi, Ali; Mirzaei-Parsa, Mohamad Javad; Shahabi, Arman.
Afiliación
  • Javdani H; Molecular Medicine Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
  • Mollaei H; Department of Biology, Faculty of Sciences, University of Birjand, Birjand, Iran.
  • Karimi F; Department of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran.
  • Mahmoudi S; Department of Medical Biotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Farahi A; Student Research Committee, Department of Molecular Medicine, Birjand University of Medical Sciences, Birjand, Iran.
  • Mirzaei-Parsa MJ; Cell Therapy and Regenerative Medicine Comprehensive Center, Kerman University of Medical Sciences, Kerman, Iran.
  • Shahabi A; Cell Therapy and Regenerative Medicine Comprehensive Center, Kerman University of Medical Sciences, Kerman, Iran. a.shahabi@kmu.ac.ir.
Mol Biol Rep ; 49(10): 9963-9973, 2022 Oct.
Article en En | MEDLINE | ID: mdl-35716288
ABSTRACT
Despite major advances, breast cancer (BC) is the most commonly diagnosed carcinoma and remains a deadly disease among women worldwide. Many researchers point toward an important role of an epithelial to mesenchymal transition (EMT) in BC development and promoting metastasis. Here, will be discussed that how functional changes of transcription factors, signaling pathways, and microRNAs (miRNA) in BC promote EMT. A thorough understanding the EMT biology can be important to determine reversing the process and design treatment approaches. There are frequent debates as to whether EMT is really relevant to BC in vivo, in which due to the intrinsic heterogeneity and tumor microenvironment. Nevertheless, given the importance of EMT in cancer progression and metastasis, the implementation of therapies against cancer-associated EMT will continue to help us develop and test potential treatments.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / MicroARNs Tipo de estudio: Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Mol Biol Rep Año: 2022 Tipo del documento: Article País de afiliación: Irán

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / MicroARNs Tipo de estudio: Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Mol Biol Rep Año: 2022 Tipo del documento: Article País de afiliación: Irán